1-8 of 8
Barbara Burroni, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy — a Study By the Lysa Group

Yannick LE Bris, MD PharmD, Olivier Theisen, MD, Anne Moreau, MD, Florence Magrangeas, PhD, Danielle Canioni, MD, Barbara Burroni, MD, Catherine Thieblemont, MD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, David Chiron, PhD, Catherine Pellat-deceunynck, PhD, Benoit Tessoulin, MD, Catherine Godon, MD, Marie-Helene Delfau, MD, Mary Callanan, PhD, Stephane Minvielle, PhD, Marie C Bene, PharmSci, PhD, Olivier Hermine, MD PhD, Steven LE Gouill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4099.
https://doi.org/10.1182/blood-2018-99-113303
Published: 2018
Journal Articles

Correlations between p16 Protein Expression and Genomic Profile in Mantle Cell Lymphoma and Impact on Survival, a Lyma-Genomic Project Conducted on Behalf of the Lysa Group

Yannick LE Bris, MDPharmD, Danielle Canioni, MD, Barbara Burroni, MD, Anne Moreau, MD, Benoit Tessoulin, MD, Florence Magrangeas, PhD, Marie-Helene Delfau, MD, Catherine Thieblemont, MD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, David Chiron, PhD, Catherine Pellat-deceunynck, PhD, Mary Callanan, PhD, Stephane Minvielle, PhD, Marie C Bene, PharmSci, PhD, Olivier Hermine, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2846.
https://doi.org/10.1182/blood-2018-99-113268
Published: 2018
Journal Articles

P53 and P16 Protein Expression Have Prognostic Value in Mantle Cell Lymphomas in the Lyma Trial in the Lysa Group

Danielle Canioni, MD, Barbara Burroni, MD, Anne Moreau, MD, Alexandra traverse-Glehen, MD PhD, Antoine Martin, MD PhD, Remy Gressin, MD, Vincent Ribrag, MD, Catherine Thieblemont, MD PhD, Marie-Helene Delfau-Larue, Elizabeth A. Macintyre, PhD FRCP, FRCPath, Mary Callanan, MD, Steven Le Gouill, MDPhD, Olivier Hermine, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4036.
https://doi.org/10.1182/blood.V130.Suppl_1.4036.4036
Published: 2017
Journal Articles

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Rudy Birsen, Estelle Blanc, MD, Barbara Burroni, MD, Chloe Broudin, MD, Lise Willems, MD, Marielle Legoff, MD, Emmanuelle Leray, MD, Sylvain Pilorge, MD, Sawsen Salah, MD, Aude Quentin, MD, Bénédicte Deau-Fisher, MD, Patricia Franchi, MD, Marguerite Vignon, MD, Laurence Mabille, MD, Charles Nguyen, MD, Youlia Kirova, MD, Pascale Varlet, MD, Arnault tauziede-Espariat, MD, Myriam Edjlali, MD, Dezamis Edouard, MD, Carole Soussain, MD PhD, Caroline Houillier, MD, Johan Pallud, MDPhD, Diane Damotte, MDPhD, Didier Bouscary, MDPhD, Jerome Tamburini Bonnefoy, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1573.
https://doi.org/10.1182/blood.V130.Suppl_1.1573.1573
Published: 2017
Journal Articles

Prognostic Value of Early 18F-FDG PET/CT Scanner Evaluation in Immunocompetent Primary CNS Lymphoma Patients

Rudy Birsen, Estelle Blanc, MD, Barbara Burroni, MD, Chloe Broudin, MD, Lise Willems, MD, Marielle Legoff, MD, Emmanuelle Leray, MD, Sylvain Pilorge, MD, Sawsen Salah, MD, Aude Quentin, MD, Bénédicte Deau-Fisher, MD, Patricia Franchi, MD, Marguerite Vignon, MD, Laurence Mabille, MD, Charles Nguyen, MD, Youlia Kirova, MD, Pascale Varlet, MD, Arnault tauziede-Espariat, MD, Myriam Edjlali, MD, Dezamis Edouard, MD, Khe Hoang-xuan, MD PhD, Caroline Houillier, MD, Carole Soussain, MD PhD, Johan Pallud, MDPhD, Diane Damotte, MDPhD, Didier Bouscary, MDPhD, Jerome Tamburini Bonnefoy, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4169.
https://doi.org/10.1182/blood.V130.Suppl_1.4169.4169
Published: 2017
Journal Articles

Efficacy of the Ribvd Regimen in High Risk Mantle Cell Lymphoma Patients As Defined By the Mipic Prognostic Score: Identification of KI67, LDH and Performance Status As Most Important Prognostic Factors (PF). a French Lysa Group Study

Remy Gressin, MD, Anne Moreau, MD, Nicolas Daguindau, MD, Adrien Tempescul, MD, Sylvain Carras, MD, Jean-Michel Pignon, MD, Guillaume Cartron, MD PhD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Anne Schmitt, MD, Krimo Bouabdallah, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Lionel Karlin, MD, Fabrice Jardin, MD PhD, Luc Mathieu Fornecker, MD PhD, Selim Corm, MD, Joel Fleury, MD, Barbara Burroni, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5302.
https://doi.org/10.1182/blood.V128.22.5302.5302
Published: 2016
Journal Articles

Temsirolimus in Combination with Three Different Immuno-Chemotherapy Regimens in Relapse and Refractory Mantle Cell Lymphoma, Final Results of the T 3 Phase IB Trial of the Lysa Group

Steven Le Gouill, MD PhD, Krimo Bouabdallah, MD, Barbara Burroni, MD, Thierry Lamy, MD PhD, Remy Gressin, MD, Guillaume Cartron, MD PhD, Catherine Thieblemont, MD PhD, Clémentine Sarkozy, MD, Corinne Haioun, MD PhD, Olivier Casasnovas, MD, Emmanuel Gyan, MD PhD, Olivier Hermine, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2987.
https://doi.org/10.1182/blood.V128.22.2987.2987
Published: 2016
Journal Articles

Clonal B-Cell Lymphocytosis with Marginal Zone Features and Splenic Marginal Zone Lymphoma Share a Similar Cytogenetic and Mutational Profile

Paul Legendre, MD, Olivier Kosmider, PharmD, PhD, Coralie Derrieux, PharmD, Nicolas Chapuis, PharmD, PhD, Isabelle Radford-Weiss, PharmD, Hélène Guermouche, Barbara Burroni, MD, Julie Bruneau, MD PhD, Bénédicte Deau, MD, Richard Delarue, MD, Olivier Hermine, MD PhD, Didier Bouscary, MD PhD, David Sibon, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2962.
https://doi.org/10.1182/blood.V128.22.2962.2962
Published: 2016